125 related articles for article (PubMed ID: 36709998)
1. Evaluation of the detection of the homologous transfusion of a red blood cell concentrate in vivo for antidoping.
Marchand A; Roulland I; Semence F; Jaffredo F; Dehainault C; Le Guiner S; Le Pajolec MG; Donati F; Mekacher LR; Lamek K; Ericsson M
Drug Test Anal; 2023; 15(11-12):1417-1429. PubMed ID: 36709998
[TBL] [Abstract][Full Text] [Related]
2. Homologous blood transfusion and doping: Where are we now?
Marchand A; Ericsson M
Drug Test Anal; 2024 Feb; ():. PubMed ID: 38403885
[TBL] [Abstract][Full Text] [Related]
3. Scientific and forensic standards for homologous blood transfusion anti-doping analyses.
Giraud S; Robinson N; Mangin P; Saugy M
Forensic Sci Int; 2008 Jul; 179(1):23-33. PubMed ID: 18514452
[TBL] [Abstract][Full Text] [Related]
4. Proof of homologous blood transfusion through quantification of blood group antigens.
Nelson M; Popp H; Sharpe K; Ashenden M
Haematologica; 2003 Nov; 88(11):1284-95. PubMed ID: 14607758
[TBL] [Abstract][Full Text] [Related]
5. Possible cause of lack of positive samples on homologous blood transfusion.
Krotov G; Nikitina M; Rodchenkov G
Drug Test Anal; 2014; 6(11-12):1160-2. PubMed ID: 25331764
[TBL] [Abstract][Full Text] [Related]
6. Investigation on the application of DNA forensic human identification techniques to detect homologous blood transfusions in doping control.
Donati F; Stampella A; de la Torre X; Botrè F
Talanta; 2013 Jun; 110():28-31. PubMed ID: 23618171
[TBL] [Abstract][Full Text] [Related]
7. Detection of homologous blood transfusion.
Voss SC; Thevis M; Schinkothe T; Schänzer W
Int J Sports Med; 2007 Aug; 28(8):633-7. PubMed ID: 17614019
[TBL] [Abstract][Full Text] [Related]
8. Minor red blood cell antigen phenotyping of athletes sampled in international competitions.
Cristina Mirotti L; Renovato-Martins M; Du Rocher-Silva B; Dudenhoeffer-Carneiro AC; Soares F; Rahaman KA; Hasan M; Muresan AR; Kwon OS; Son JJ; Pereira HMG
Drug Test Anal; 2023 Mar; 15(3):292-298. PubMed ID: 36346023
[TBL] [Abstract][Full Text] [Related]
9. Red blood cell populations and membrane levels of peroxiredoxin 2 as candidate biomarkers to reveal blood doping.
Marrocco C; Pallotta V; D'alessandro A; Alves G; Zolla L
Blood Transfus; 2012 May; 10 Suppl 2(Suppl 2):s71-7. PubMed ID: 22890272
[TBL] [Abstract][Full Text] [Related]
10. Detecting Autologous Blood Transfusion in Doping Control: Biomarkers of Blood Aging and Storage Measured by Flow Cytofluorimetry.
Donati F; Acciarini R; De Benedittis I; de la Torre X; Pirri D; Prete M; Stampella A; Vernucci E; Botre F
Curr Pharm Biotechnol; 2018; 19(2):124-135. PubMed ID: 29621963
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Application of DNA-based forensic analysis for the detection of homologous transfusion of whole blood and of red blood cell concentrates in doping control.
Stampella A; Di Marco S; Pirri D; de la Torre X; Botrè F; Donati F
Forensic Sci Int; 2016 Aug; 265():204-10. PubMed ID: 27175858
[TBL] [Abstract][Full Text] [Related]
13. Blood doping in athletes--detection of allogeneic blood transfusions by flow cytofluorometry.
Arndt PA; Kumpel BM
Am J Hematol; 2008 Aug; 83(8):657-67. PubMed ID: 18508326
[TBL] [Abstract][Full Text] [Related]
14. Assessment of common red blood cell pretreatments to yield an accurate serologic antigen phenotype compared with genotype-predicted phenotype.
Horn T; Hamilton J; Kosanke J; Hare VW; Kluver W; Beres W; Nance S; Keller MA
Immunohematology; 2019; 33(4):147-151. PubMed ID: 34841814
[TBL] [Abstract][Full Text] [Related]
15. Blood transfusions in athletes. Old dogmas, new tricks.
Lippi G; Banfi G
Clin Chem Lab Med; 2006; 44(12):1395-402. PubMed ID: 17163813
[TBL] [Abstract][Full Text] [Related]
16. Phenotype matching of donor red blood cell units for nonalloimmunized sickle cell disease patients: a survey of 1182 North American laboratories.
Osby M; Shulman IA
Arch Pathol Lab Med; 2005 Feb; 129(2):190-3. PubMed ID: 15679419
[TBL] [Abstract][Full Text] [Related]
17. Analysis of RBC-microparticles in stored whole blood bags - a promising marker to detect blood doping in sports?
Voss SC; Jaganjac M; Al-Thani AM; Grivel JC; Raynaud CM; Al-Jaber H; Al-Menhali AS; Merenkov ZA; Alsayrafi M; Latiff A; Georgakopoulos C
Drug Test Anal; 2017 Nov; 9(11-12):1794-1798. PubMed ID: 28474406
[TBL] [Abstract][Full Text] [Related]
18. A and B antigen levels acquired by group O donor-derived erythrocytes following ABO-non-identical transfusion or minor ABO-incompatible haematopoietic stem cell transplantation.
Hult AK; Dykes JH; Storry JR; Olsson ML
Transfus Med; 2017 Jun; 27(3):181-191. PubMed ID: 28401678
[TBL] [Abstract][Full Text] [Related]
19. Red blood cell derived extracellular vesicles during the process of autologous blood doping.
Voss SC; Yassin M; Grivel JC; Al Hmissi S; Allahverdi N; Nashwan A; Merenkov Z; Abdulla M; Al Malki A; Raynaud C; Elsaftawy W; Al Kaabi A; Donati F; Botre F; Mohamed Ali V; Georgakopoulos C; Al Maadheed M
Drug Test Anal; 2022 Nov; 14(11-12):1984-1994. PubMed ID: 34453778
[TBL] [Abstract][Full Text] [Related]
20. Concise review: stem cell-derived erythrocytes as upcoming players in blood transfusion.
Zeuner A; Martelli F; Vaglio S; Federici G; Whitsett C; Migliaccio AR
Stem Cells; 2012 Aug; 30(8):1587-96. PubMed ID: 22644674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
